Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. (يفتح نافذة جديدة)

Arbach O, Funck R, Seibt F, Salama A.

Source‎: Transfus Med Hemother 2012;39(3):221-3.

مفهرسة‎: PubMed 22851939

DOI‎: 10.1159/000339260

https://www.ncbi.nlm.nih.gov/pubmed/22851939 (يفتح نافذة جديدة)

The changing spectrum of drug-induced immune hemolytic anemia. (يفتح نافذة جديدة)

Arndt PA, Garratty G.

Source‎: Semin Hematol 2005;42(3):137-44.

مفهرسة‎: PubMed 16041663

https://www.ncbi.nlm.nih.gov/pubmed/16041663 (يفتح نافذة جديدة)

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. (يفتح نافذة جديدة)

Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Battista ML, Di Bona E, Fattizzo B, Consonni D, Cortelezzi A, Fanin R, Zanella A.

Source‎: Blood 2012;119(16):3691-7.

مفهرسة‎: PubMed 22267606

DOI‎: 10.1182/blood-2011-06-363556

https://www.ncbi.nlm.nih.gov/pubmed/22267606 (يفتح نافذة جديدة)

Autoimmune hemolytic anemia. (يفتح نافذة جديدة)

Gehrs BC, Friedberg RC.

Source‎: Am J Hematol 2002;69(4):258-71.

مفهرسة‎: PubMed 11921020

https://www.ncbi.nlm.nih.gov/pubmed/11921020 (يفتح نافذة جديدة)

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias. (يفتح نافذة جديدة)

Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L, Herrera-Garza JL, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Jaime-Pérez JC.

Source‎: Blood 2010;116(23):4783-5.

مفهرسة‎: PubMed 20841509

DOI‎: 10.1182/blood-2010-06-291831

https://www.ncbi.nlm.nih.gov/pubmed/20841509 (يفتح نافذة جديدة)

A case of late-onset systemic lupus erythematosus with severe anemia. (يفتح نافذة جديدة)

Matsumoto M, Kaieda S, Honda S, Ida H, Hoshino T, Fukuda T.

Source‎: Kurume Med J 2013;60(1):25-8.

مفهرسة‎: PubMed 23925156

https://www.ncbi.nlm.nih.gov/pubmed/23925156 (يفتح نافذة جديدة)

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. (يفتح نافذة جديدة)

Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA.

Source‎: Blood 2002;100(2):704-6.

مفهرسة‎: PubMed 12091370

DOI‎: 10.1182/blood-2002-01-0087

https://www.ncbi.nlm.nih.gov/pubmed/12091370 (يفتح نافذة جديدة)

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. (يفتح نافذة جديدة)

Zecca M, De Stefano P, Nobili B, Locatelli F.

Source‎: Blood 2001;97(12):3995-7.

مفهرسة‎: PubMed 11389047

https://www.ncbi.nlm.nih.gov/pubmed/11389047 (يفتح نافذة جديدة)

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. (يفتح نافذة جديدة)

Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, Jankovic M, Pierani P, De Stefano P, Bonora MR, Locatelli F.

Source‎: Blood 2003;101(10):3857-61.

مفهرسة‎: PubMed 12531800

DOI‎: 10.1182/blood-2002-11-3547

https://www.ncbi.nlm.nih.gov/pubmed/12531800 (يفتح نافذة جديدة)